Symbol:
Acadvl
Name:
acyl-CoA dehydrogenase, very long chain
RGD ID:
2014
Description:
Enables acyl-CoA dehydrogenase activity and heterocyclic compound binding activity. Involved in fatty acid beta-oxidation. Located in mitochondrial inner membrane. Biomarker of metabolic dysfunction-associated steatotic liver disease. Human ortholog(s) of this gene implicated in very long chain acyl-CoA dehydrogenase deficiency. Orthologous to human ACADVL (acyl-CoA dehydrogenase very long chain); PARTICIPATES IN fatty acid beta degradation pathway; carnitine palmitoyltransferase I deficiency pathway; ethylmalonic encephalopathy pathway; INTERACTS WITH 1,2,4-trimethylbenzene; 6-propyl-2-thiouracil; acetamide.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
Acyl-Coa dehydrogenase Very long chain; acyl-Coenzyme A dehydrogenase, very long chain; MGC93660; Very long chain Acyl-Coa dehydrogenase; very long-chain specific acyl-CoA dehydrogenase, mitochondrial; VLCAD; VLCAD very-long-chain acyl-CoA dehydrogenase; VLCAD, very-long-chain acyl-CoA dehydrogenase
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Species
Gene symbol and name
Data Source
Assertion derived from
less info ...
Orthologs 1
Homo sapiens (human):
ACADVL (acyl-CoA dehydrogenase very long chain)
HGNC
EggNOG, Ensembl, HomoloGene, Inparanoid, NCBI, OMA, OrthoDB, OrthoMCL, Panther, Treefam
Mus musculus (house mouse):
Acadvl (acyl-Coenzyme A dehydrogenase, very long chain)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chinchilla lanigera (long-tailed chinchilla):
Acadvl (acyl-CoA dehydrogenase very long chain)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Pan paniscus (bonobo/pygmy chimpanzee):
ACADVL (acyl-CoA dehydrogenase very long chain)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Canis lupus familiaris (dog):
ACADVL (acyl-CoA dehydrogenase very long chain)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Ictidomys tridecemlineatus (thirteen-lined ground squirrel):
Acadvl (acyl-CoA dehydrogenase very long chain)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Sus scrofa (pig):
ACADVL (acyl-CoA dehydrogenase very long chain)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Chlorocebus sabaeus (green monkey):
ACADVL (acyl-CoA dehydrogenase very long chain)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Heterocephalus glaber (naked mole-rat):
Acadvl (acyl-CoA dehydrogenase very long chain)
Transitive Ortholog Pipeline
Transitive Ortholog Pipeline
Alliance orthologs 3
Mus musculus (house mouse):
Acadvl (acyl-Coenzyme A dehydrogenase, very long chain)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Homo sapiens (human):
ACADVL (acyl-CoA dehydrogenase very long chain)
Alliance
DIOPT (Ensembl Compara|HGNC|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Danio rerio (zebrafish):
acadvl (acyl-CoA dehydrogenase very long chain)
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Drosophila melanogaster (fruit fly):
CG7461
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Caenorhabditis elegans (roundworm):
acdh-12
Alliance
DIOPT (Ensembl Compara|Hieranoid|InParanoid|OMA|OrthoFinder|OrthoInspector|PANTHER|PhylomeDB|SonicParanoid)
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 55,231,558 - 55,236,786 (-) NCBI GRCr8 mRatBN7.2 10 54,732,875 - 54,738,102 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 54,732,469 - 54,738,075 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 59,395,021 - 59,400,168 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 58,883,601 - 58,888,748 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 54,390,891 - 54,396,038 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 56,619,321 - 56,624,468 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 56,619,303 - 56,624,526 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 56,364,440 - 56,369,587 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 56,856,233 - 56,861,380 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 56,869,857 - 56,875,003 (-) NCBI Celera 10 53,886,459 - 53,891,606 (-) NCBI Celera Cytogenetic Map 10 q24 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Acadvl Rat autism spectrum disorder ISO RGD:735407 8554872 ClinVar Annotator: match by term: Autism spectrum disorder ClinVar PMID:30504930 Acadvl Rat autosomal dominant intellectual developmental disorder 62 ISO RGD:735407 8554872 ClinVar Annotator: match by term: DLG4-related condition | ClinVar Annotator: match by term: Intellectual developmental more ... ClinVar PMID:25741868|PMID:27618451 Acadvl Rat Cardiac Arrhythmias ISO RGD:735407 8554872 ClinVar Annotator: match by term: Cardiac arrhythmia ClinVar PMID:11590124|PMID:25741868|PMID:28492532|PMID:28755359|PMID:9973285 Acadvl Rat common variable immunodeficiency ISO RGD:735407 8554872 ClinVar Annotator: match by term: Common variable immunodeficiency ClinVar PMID:28492532 Acadvl Rat congenital myasthenic syndrome 2A ISO RGD:735407 8554872 ClinVar Annotator: match by term: Congenital myasthenic syndrome 2A ClinVar PMID:28492532 Acadvl Rat developmental and epileptic encephalopathy 25 ISO RGD:735407 8554872 ClinVar Annotator: match by term: Developmental and epileptic encephalopathy, 25 ClinVar PMID:28492532 Acadvl Rat dilated cardiomyopathy ISO RGD:735407 8554872 ClinVar Annotator: match by term: Primary dilated cardiomyopathy ClinVar PMID:18227065|PMID:21932095|PMID:25087612|PMID:25741868|PMID:26385305|PMID:27209629|PMID:28468868|PMID:28492532|PMID:31031081|PMID:34437764|PMID:35281659|PMID:9599005 Acadvl Rat dyskeratosis congenita ISO RGD:735407 8554872 ClinVar Annotator: match by term: Dyskeratosis congenita ClinVar PMID:28492532 Acadvl Rat familial hypertrophic cardiomyopathy ISO RGD:735407 8554872 ClinVar Annotator: match by term: Primary familial hypertrophic cardiomyopathy ClinVar Acadvl Rat Faundes-Banka Syndrome ISO RGD:735407 8554872 ClinVar Annotator: match by term: Faundes-Banka syndrome ClinVar PMID:31690835 Acadvl Rat genetic disease ISO RGD:735407 8554872 ClinVar Annotator: match by term: Inborn genetic diseases ClinVar PMID:10077518|PMID:11590124|PMID:12208138|PMID:12213615|PMID:14517516|PMID:16860141|PMID:17374501|PMID:17576681|PMID:17999356|PMID:18227065|PMID:19208414|PMID:19327992|PMID:20107901|PMID:20301763|PMID:21429517|PMID:21932095|PMID:23169530|PMID:23418865|PMID:23430948|PMID:23480858|PMID:23798014|PMID:23867825|PMID:24033266|PMID:24503138|PMID:24801231|PMID:25087612|PMID:25214167|PMID:25741868|PMID:25843429|PMID:26385305|PMID:26743058|PMID:26937394|PMID:27209629|PMID:27246109|PMID:28468868|PMID:28492532|PMID:28518168|PMID:28747690|PMID:28755359|PMID:28871440|PMID:30194637|PMID:30504930|PMID:30904546|PMID:31031081|PMID:31589614|PMID:32054689|PMID:32061778|PMID:32461654|PMID:32518924|PMID:32710939|PMID:32778825|PMID:32928639|PMID:32954689|PMID:34106991|PMID:34194748|PMID:34437764|PMID:34564390|PMID:35267200|PMID:35281659|PMID:35281663|PMID:35400565|PMID:7479827|PMID:8739957|PMID:8845838|PMID:9536098|PMID:9599005|PMID:9973285 Acadvl Rat intellectual disability ISO RGD:735407 8554872 ClinVar Annotator: match by term: Intellectual disability, mild ClinVar Acadvl Rat Li-Fraumeni syndrome ISO RGD:735407 8554872 ClinVar Annotator: match by term: Li-Fraumeni syndrome ClinVar PMID:20522432|PMID:21056402|PMID:23172776|PMID:26681312|PMID:28492532 Acadvl Rat myopathy ISO RGD:735407 8554872 ClinVar Annotator: match by term: Myopathy ClinVar PMID:14517516|PMID:19327992|PMID:20060901|PMID:21429517|PMID:23798014|PMID:25214167|PMID:25741868|PMID:26385305|PMID:28492532|PMID:30194637|PMID:30904546|PMID:31589614|PMID:32710939|PMID:34106991|PMID:9973285 Acadvl Rat pancreatic hypoplasia-diabetes-congenital heart disease syndrome ISO RGD:735407 8554872 ClinVar Annotator: match by term: Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ClinVar PMID:25741868 Acadvl Rat Pearson syndrome ISO RGD:735407 8554872 ClinVar Annotator: match by term: Pearson syndrome ClinVar PMID:25741868|PMID:28492532 Acadvl Rat Rhabdomyolysis ISO RGD:735407 8554872 ClinVar Annotator: match by term: Rhabdomyolysis ClinVar PMID:11158518|PMID:14517516|PMID:15210884|PMID:19327992|PMID:20060901|PMID:21429517|PMID:23798014|PMID:24801231|PMID:25214167|PMID:25741868|PMID:26385305|PMID:28492532|PMID:30194637|PMID:30904546|PMID:31589614|PMID:32581362|PMID:32710939|PMID:34106991|PMID:35400565|PMID:9546340|PMID:9973285 Acadvl Rat very long chain acyl-CoA dehydrogenase deficiency ISO RGD:735407 8554872 ClinVar Annotator: match by term: Very long chain acyl-CoA dehydrogenase deficiency ClinVar PMID:10077518|PMID:10384387|PMID:10431122|PMID:10518280|PMID:10529389|PMID:10738914|PMID:10790204|PMID:11158518|PMID:11349232|PMID:11590124|PMID:11914034|PMID:12122118|PMID:12208138|PMID:12213615|PMID:14517516|PMID:14728674|PMID:15210884|PMID:16199547|PMID:16435213|PMID:16443431|PMID:16464760|PMID:16488171|PMID:16860141|PMID:16895136|PMID:16950999|PMID:16982043|PMID:17206456|PMID:17374501|PMID:17514507|PMID:17576681|PMID:17999356|PMID:18227065|PMID:18414213|PMID:18670371|PMID:19208414|PMID:19327992|PMID:20056241|PMID:2006090|PMID:20060901|PMID:20107901|PMID:20301763|PMID:20480395|PMID:20547398|PMID:20694756|PMID:21228398|PMID:21378393|PMID:21429517|PMID:21531094|PMID:21814341|PMID:21932095|PMID:22494076|PMID:22841441|PMID:22847164|PMID:23169530|PMID:23418865|PMID:23430948|PMID:23430950|PMID:23480858|PMID:23700290|PMID:23757202|PMID:23774949|PMID:23798014|PMID:23867825|PMID:23966064|PMID:24033266|PMID:24263034|PMID:24305961|PMID:24503138|PMID:24801231|PMID:24898617|PMID:25085675|PMID:25087612|PMID:25214167|PMID:25242572|PMID:25338548|PMID:25456746|PMID:25525159|PMID:25652019|PMID:25655073|PMID:25737446|PMID:25741868|PMID:25834949|PMID:25843429|PMID:26182500|PMID:26385305|PMID:26453363|PMID:26602010|PMID:26743058|PMID:26881790|PMID:26927351|PMID:26937394|PMID:26982752|PMID:27029698|PMID:27209629|PMID:27246109|PMID:27538624|PMID:27884173|PMID:27943070|PMID:27995075|PMID:28468868|PMID:28492532|PMID:28518168|PMID:28600779|PMID:28747690|PMID:28755339|PMID:28755359|PMID:28871440|PMID:29111448|PMID:29268767|PMID:2951924|PMID:29519241|PMID:29552494|PMID:29768383|PMID:29961767|PMID:30023301|PMID:30194637|PMID:30904546|PMID:30950014|PMID:31031081|PMID:31191348|PMID:31497477|PMID:31589614|PMID:31620161|PMID:31737040|PMID:31794763|PMID:31983732|PMID:32054689|PMID:32061778|PMID:32276429|PMID:32380161|PMID:32461654|PMID:32518924|PMID:32558070|PMID:32581362|PMID:32655480|PMID:32669490|PMID:32710939|PMID:32778825|PMID:32793418|PMID:32798077|PMID:32860008|PMID:32928639|PMID:32954689|PMID:33123633|PMID:33150772|PMID:33549744|PMID:33610471|PMID:33965301|PMID:33986768|PMID:33996489|PMID:34106991|PMID:34184355|PMID:34194748|PMID:34426522|PMID:34437764|PMID:34480364|PMID:34485012|PMID:34564390|PMID:34704412|PMID:35095998|PMID:35193651|PMID:35218577|PMID:35267200|PMID:35281659|PMID:35281663|PMID:35400565|PMID:35626289|PMID:36078043|PMID:36109795|PMID:36356723|PMID:38015438|PMID:4022672|PMID:609575|PMID:7479827|PMID:7668252|PMID:7769092|PMID:8554073|PMID:8739957|PMID:8845838|PMID:9461620|PMID:9536098|PMID:9546340|PMID:9599005|PMID:9709714|PMID:9839948|PMID:9973285 Acadvl Rat Weissenbacher-Zweymuller syndrome ISO RGD:735407 8554872 ClinVar Annotator: match by term: Glossoptosis, micrognathia, and cleft palate ClinVar
Only show annotations with direct experimental evidence (0 objects hidden)
Acadvl Rat 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of ACADVL protein CTD PMID:17337753 Acadvl Rat 1,2-dimethylhydrazine decreases expression ISO RGD:10058 6480464 1,2-Dimethylhydrazine results in decreased expression of ACADVL mRNA CTD PMID:22206623 Acadvl Rat 1,4-benzoquinone decreases expression ISO RGD:735407 6480464 quinone results in decreased expression of ACADVL mRNA CTD PMID:32478940 Acadvl Rat 17beta-estradiol decreases expression ISO RGD:10058 6480464 Estradiol results in decreased expression of ACADVL mRNA CTD PMID:19484750 Acadvl Rat 17beta-estradiol increases expression ISO RGD:10058 6480464 Estradiol results in increased expression of ACADVL mRNA CTD PMID:39298647 Acadvl Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:10058 6480464 2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of ACADVL mRNA CTD PMID:38040069 Acadvl Rat 2,2',5,5'-tetrachlorobiphenyl decreases expression ISO RGD:735407 6480464 2,5,2',5'-tetrachlorobiphenyl results in decreased expression of ACADVL mRNA CTD PMID:36804509 Acadvl Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:10058 6480464 Tetrachlorodibenzodioxin affects the expression of ACADVL mRNA CTD PMID:21570461 Acadvl Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:735407 6480464 Tetrachlorodibenzodioxin results in increased expression of ACADVL mRNA CTD PMID:11489354|PMID:20106945|PMID:21632981|PMID:21807756 Acadvl Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO RGD:10058 6480464 2,2',4,4',5-brominated diphenyl ether affects the expression of ACADVL mRNA CTD PMID:38648751 Acadvl Rat 2,6-dimethoxyphenol multiple interactions ISO RGD:735407 6480464 [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization more ... CTD PMID:38598786 Acadvl Rat 2-palmitoylglycerol increases expression ISO RGD:735407 6480464 2-palmitoylglycerol results in increased expression of ACADVL mRNA CTD PMID:37199045 Acadvl Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:10058 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACADVL mRNA CTD PMID:23428407 Acadvl Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:10058 6480464 bisphenol S results in increased expression of ACADVL mRNA CTD PMID:39298647 Acadvl Rat 4,4'-sulfonyldiphenol increases expression ISO RGD:735407 6480464 bisphenol S results in increased expression of ACADVL protein CTD PMID:34186270 Acadvl Rat 4,4'-sulfonyldiphenol affects methylation ISO RGD:10058 6480464 bisphenol S affects the methylation of ACADVL gene CTD PMID:31683443 Acadvl Rat 4-hydroxyphenyl retinamide increases expression ISO RGD:735407 6480464 Fenretinide results in increased expression of ACADVL mRNA CTD PMID:16671099 Acadvl Rat 4-hydroxyphenyl retinamide increases expression ISO RGD:10058 6480464 Fenretinide results in increased expression of ACADVL mRNA CTD PMID:28973697 Acadvl Rat 5-aza-2'-deoxycytidine increases expression ISO RGD:735407 6480464 Decitabine results in increased expression of ACADVL mRNA CTD PMID:19151715 Acadvl Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ACADVL mRNA CTD PMID:24780913 Acadvl Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of ACADVL mRNA CTD PMID:31881176 Acadvl Rat actinomycin D multiple interactions ISO RGD:735407 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion more ... CTD PMID:38460933 Acadvl Rat aflatoxin B1 increases expression ISO RGD:10058 6480464 Aflatoxin B1 results in increased expression of ACADVL mRNA CTD PMID:19770486 Acadvl Rat all-trans-retinoic acid increases expression ISO RGD:735407 6480464 Tretinoin results in increased expression of ACADVL mRNA CTD PMID:23724009|PMID:33167477 Acadvl Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of ACADVL mRNA CTD PMID:16483693 Acadvl Rat antimycin A decreases expression ISO RGD:735407 6480464 Antimycin A results in decreased expression of ACADVL mRNA CTD PMID:33512557 Acadvl Rat aristolochic acid A increases expression ISO RGD:735407 6480464 aristolochic acid I results in increased expression of ACADVL mRNA; aristolochic acid I results in more ... CTD PMID:33212167 Acadvl Rat Aroclor 1254 decreases expression ISO RGD:10058 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ACADVL mRNA CTD PMID:23650126 Acadvl Rat arsane multiple interactions ISO RGD:735407 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ACADVL more ... CTD PMID:32525701 Acadvl Rat arsenic atom multiple interactions ISO RGD:735407 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ACADVL more ... CTD PMID:32525701 Acadvl Rat aspartame multiple interactions ISO RGD:10058 6480464 [Fats, Unsaturated co-treated with Aspartame] affects the expression of ACADVL mRNA; [Fats, Unsaturated co-treated with more ... CTD PMID:23783067 Acadvl Rat atrazine increases expression ISO RGD:735407 6480464 Atrazine results in increased expression of ACADVL mRNA CTD PMID:22378314 Acadvl Rat azoxystrobin decreases expression ISO RGD:735407 6480464 azoxystrobin results in decreased expression of ACADVL mRNA CTD PMID:33512557 Acadvl Rat benzo[a]pyrene multiple interactions ISO RGD:10058 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ACADVL mRNA] CTD PMID:22228805 Acadvl Rat benzo[a]pyrene decreases methylation ISO RGD:735407 6480464 Benzo(a)pyrene results in decreased methylation of ACADVL promoter CTD PMID:27901495 Acadvl Rat beta-lapachone increases expression ISO RGD:735407 6480464 beta-lapachone results in increased expression of ACADVL mRNA CTD PMID:38218311 Acadvl Rat beta-lapachone decreases expression ISO RGD:735407 6480464 beta-lapachone results in decreased expression of ACADVL mRNA CTD PMID:38218311 Acadvl Rat bezafibrate affects response to substance ISO RGD:735407 6480464 ACADVL protein affects the susceptibility to Bezafibrate; ACADVL protein mutant form affects the susceptibility to more ... CTD PMID:17999356|PMID:20060901 Acadvl Rat bezafibrate increases expression ISO RGD:10058 6480464 Bezafibrate results in increased expression of ACADVL mRNA; Bezafibrate results in increased expression of ACADVL more ... CTD PMID:12782154|PMID:17118139|PMID:22338096 Acadvl Rat bezafibrate multiple interactions ISO RGD:735407 6480464 Bezafibrate inhibits the reaction [ACADVL protein mutant form results in decreased oxidation of Fatty Acids] CTD PMID:20060901 Acadvl Rat bezafibrate multiple interactions ISO RGD:10058 6480464 Butyrates promotes the reaction [Bezafibrate results in increased expression of ACADVL mRNA]; PPARA protein affects more ... CTD PMID:12782154|PMID:22338096 Acadvl Rat bezafibrate increases expression ISO RGD:735407 6480464 Bezafibrate results in increased expression of ACADVL mRNA CTD PMID:17999356 Acadvl Rat bezafibrate increases activity ISO RGD:735407 6480464 Bezafibrate results in increased activity of ACADVL protein CTD PMID:17999356 Acadvl Rat bis(2-ethylhexyl) phthalate increases expression ISO RGD:10058 6480464 Diethylhexyl Phthalate results in increased expression of ACADVL mRNA CTD PMID:19850644 Acadvl Rat bis(2-ethylhexyl) phthalate increases expression EXP 6480464 Diethylhexyl Phthalate results in increased expression of ACADVL mRNA CTD PMID:22672789 Acadvl Rat bis(2-ethylhexyl) phthalate increases expression ISO RGD:735407 6480464 Diethylhexyl Phthalate results in increased expression of ACADVL mRNA CTD PMID:21354252 Acadvl Rat bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:10058 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ACADVL mRNA] CTD PMID:19850644 Acadvl Rat bisphenol A multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in increased expression of ACADVL protein CTD PMID:26930160 Acadvl Rat bisphenol A decreases expression ISO RGD:735407 6480464 bisphenol A results in decreased expression of ACADVL protein CTD PMID:34186270 Acadvl Rat bisphenol A multiple interactions ISO RGD:735407 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ACADVL gene CTD PMID:31601247 Acadvl Rat bisphenol A increases expression ISO RGD:735407 6480464 bisphenol A results in increased expression of ACADVL protein CTD PMID:37567409 Acadvl Rat bisphenol A affects expression ISO RGD:735407 6480464 bisphenol A affects the expression of ACADVL mRNA CTD PMID:30903817 Acadvl Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ACADVL mRNA CTD PMID:30816183|PMID:32528016|PMID:34947998 Acadvl Rat bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ACADVL gene CTD PMID:28505145 Acadvl Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ACADVL mRNA; bisphenol A results in increased expression more ... CTD PMID:25181051|PMID:32145629 Acadvl Rat bisphenol AF increases expression ISO RGD:735407 6480464 bisphenol AF results in increased expression of ACADVL protein CTD PMID:34186270 Acadvl Rat Bisphenol B increases expression ISO RGD:735407 6480464 bisphenol B results in increased expression of ACADVL protein CTD PMID:34186270 Acadvl Rat bisphenol F increases expression ISO RGD:735407 6480464 bisphenol F results in increased expression of ACADVL protein CTD PMID:34186270 Acadvl Rat Brodifacoum increases expression EXP 6480464 bromfenacoum results in increased expression of ACADVL protein CTD PMID:28903499 Acadvl Rat butan-1-ol multiple interactions ISO RGD:735407 6480464 [[Gasoline co-treated with 1-Butanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic more ... CTD PMID:29432896 Acadvl Rat cadmium atom increases oxidation ISO RGD:10058 6480464 Cadmium results in increased oxidation of ACADVL protein CTD PMID:24496640 Acadvl Rat cadmium atom multiple interactions ISO RGD:735407 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACADVL more ... CTD PMID:35301059 Acadvl Rat cadmium dichloride multiple interactions ISO RGD:735407 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of ACADVL more ... CTD PMID:35301059 Acadvl Rat cannabidiol decreases expression ISO RGD:735407 6480464 Cannabidiol results in decreased expression of ACADVL protein CTD PMID:34122009 Acadvl Rat CHIR 99021 decreases expression ISO RGD:10058 6480464 Chir 99021 results in decreased expression of ACADVL mRNA CTD PMID:29883716 Acadvl Rat chlorpyrifos decreases expression ISO RGD:10058 6480464 Chlorpyrifos results in decreased expression of ACADVL mRNA CTD PMID:37019170 Acadvl Rat ciglitazone multiple interactions ISO RGD:735407 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACADVL mRNA CTD PMID:16197558 Acadvl Rat cisplatin multiple interactions ISO RGD:735407 6480464 [Piroxicam co-treated with Cisplatin] results in decreased expression of ACADVL mRNA CTD PMID:21858171 Acadvl Rat clofibrate increases expression EXP 6480464 Clofibrate results in increased expression of ACADVL mRNA CTD PMID:18670166|PMID:27665778 Acadvl Rat Clofop multiple interactions ISO RGD:735407 6480464 [fenofibric acid binds to PPARA protein] which results in increased expression of ACADVL mRNA CTD PMID:16197558 Acadvl Rat copper atom multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADVL mRNA CTD PMID:25813056 Acadvl Rat copper atom decreases expression EXP 6480464 Copper deficiency results in decreased expression of ACADVL mRNA; Copper results in decreased expression of more ... CTD PMID:19821111|PMID:22465980 Acadvl Rat copper(0) multiple interactions EXP 6480464 [Fructose co-treated with Copper deficiency] results in decreased expression of ACADVL mRNA CTD PMID:25813056 Acadvl Rat copper(0) decreases expression EXP 6480464 Copper deficiency results in decreased expression of ACADVL mRNA; Copper results in decreased expression of more ... CTD PMID:19821111|PMID:22465980 Acadvl Rat cyclosporin A decreases expression ISO RGD:10058 6480464 Cyclosporine results in decreased expression of ACADVL mRNA CTD PMID:19770486 Acadvl Rat cyclosporin A increases expression ISO RGD:735407 6480464 Cyclosporine results in increased expression of ACADVL mRNA CTD PMID:25562108 Acadvl Rat dexamethasone multiple interactions ISO RGD:10058 6480464 [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of ACADVL mRNA CTD PMID:23428407 Acadvl Rat dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of ACADVL mRNA CTD PMID:21266533 Acadvl Rat doxorubicin decreases expression ISO RGD:10058 6480464 Doxorubicin results in decreased expression of ACADVL mRNA; Doxorubicin results in decreased expression of ACADVL more ... CTD PMID:16144979|PMID:26873546|PMID:34246718 Acadvl Rat doxorubicin affects expression ISO RGD:735407 6480464 Doxorubicin affects the expression of ACADVL protein CTD PMID:29385562 Acadvl Rat endosulfan decreases expression EXP 6480464 Endosulfan results in decreased expression of ACADVL mRNA CTD PMID:29391264 Acadvl Rat epoxiconazole decreases expression ISO RGD:10058 6480464 epoxiconazole results in decreased expression of ACADVL mRNA CTD PMID:35436446 Acadvl Rat ethanol multiple interactions ISO RGD:735407 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic more ... CTD PMID:29432896 Acadvl Rat fenamidone increases expression ISO RGD:10058 6480464 fenamidone results in increased expression of ACADVL mRNA CTD PMID:27029645 Acadvl Rat fenofibrate increases expression ISO RGD:10058 6480464 Fenofibrate results in increased expression of ACADVL mRNA CTD PMID:17118139 Acadvl Rat fenofibrate increases expression ISO RGD:735407 6480464 Fenofibrate results in increased expression of ACADVL mRNA CTD PMID:24752549 Acadvl Rat fenofibrate increases expression EXP 6480464 Fenofibrate results in increased expression of ACADVL mRNA CTD PMID:27665778 Acadvl Rat flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of ACADVL mRNA CTD PMID:18035473 Acadvl Rat flutamide increases expression EXP 6480464 Flutamide results in increased expression of ACADVL mRNA CTD PMID:21525395 Acadvl Rat flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of ACADVL mRNA CTD PMID:24793618 Acadvl Rat fructose multiple interactions EXP 6480464 [Fructose co-treated with bisphenol A] results in increased expression of ACADVL protein; [Fructose co-treated with more ... CTD PMID:25813056|PMID:26930160 Acadvl Rat fulvestrant multiple interactions ISO RGD:735407 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of ACADVL gene CTD PMID:31601247 Acadvl Rat furan decreases methylation EXP 6480464 furan results in decreased methylation of ACADVL gene CTD PMID:22079235 Acadvl Rat furfural multiple interactions ISO RGD:735407 6480464 [pyrogallol 1,3-dimethyl ether co-treated with Furaldehyde] results in increased expression of and affects the localization more ... CTD PMID:38598786 Acadvl Rat gemfibrozil affects expression EXP 6480464 Gemfibrozil affects the expression of ACADVL mRNA CTD PMID:27665778 Acadvl Rat gold atom multiple interactions ISO RGD:735407 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of ACADVL mRNA CTD PMID:28433809 Acadvl Rat gold(0) multiple interactions ISO RGD:735407 6480464 [Polyethyleneimine binds to Gold] which results in decreased expression of ACADVL mRNA CTD PMID:28433809 Acadvl Rat GW 4064 multiple interactions ISO RGD:735407 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACADVL mRNA CTD PMID:30611723 Acadvl Rat GW 501516 multiple interactions ISO RGD:735407 6480464 [GW 501516 binds to PPARD protein] which results in increased expression of ACADVL mRNA CTD PMID:16197558 Acadvl Rat GW 7647 increases expression ISO RGD:735407 6480464 GW 7647 results in increased expression of ACADVL mRNA CTD PMID:30611723 Acadvl Rat GW 7647 multiple interactions ISO RGD:735407 6480464 [GW 7647 co-treated with Oleic Acid] results in increased expression of ACADVL mRNA CTD PMID:30611723 Acadvl Rat haloperidol decreases expression ISO RGD:735407 6480464 Haloperidol results in decreased expression of ACADVL protein CTD PMID:34122009 Acadvl Rat indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of ACADVL mRNA CTD PMID:36868495 Acadvl Rat isoprenaline multiple interactions EXP 6480464 [Isoproterenol co-treated with POSTN protein] results in decreased expression of ACADVL mRNA CTD PMID:30303030 Acadvl Rat isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of ACADVL mRNA CTD PMID:30303030 Acadvl Rat isotretinoin decreases expression ISO RGD:735407 6480464 Isotretinoin results in decreased expression of ACADVL mRNA CTD PMID:20436886 Acadvl Rat ivermectin decreases expression ISO RGD:735407 6480464 Ivermectin results in decreased expression of ACADVL protein CTD PMID:32959892 Acadvl Rat leflunomide increases expression EXP 6480464 leflunomide results in increased expression of ACADVL mRNA CTD PMID:24136188 Acadvl Rat lithocholic acid decreases expression ISO RGD:10058 6480464 Lithocholic Acid results in decreased expression of ACADVL mRNA CTD PMID:20359477 Acadvl Rat meldonium affects expression ISO RGD:10058 6480464 3-(2,2,2-trimethylhydrazine)propionate affects the expression of ACADVL mRNA CTD PMID:32389661 Acadvl Rat methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of ACADVL mRNA CTD PMID:30467583 Acadvl Rat methotrexate increases expression ISO RGD:735407 6480464 Methotrexate results in increased expression of ACADVL mRNA CTD PMID:17400583 Acadvl Rat microcystin-LR decreases expression ISO RGD:10058 6480464 cyanoginosin LR results in decreased expression of ACADVL protein CTD PMID:26984711 Acadvl Rat mitoxantrone decreases expression ISO RGD:10058 6480464 Mitoxantrone results in decreased expression of ACADVL protein CTD PMID:34246718 Acadvl Rat monosodium L-glutamate multiple interactions ISO RGD:10058 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of ACADVL mRNA; more ... CTD PMID:23783067 Acadvl Rat Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of ACADVL mRNA CTD PMID:21515302 Acadvl Rat nitrates multiple interactions ISO RGD:10058 6480464 [Particulate Matter results in increased abundance of Nitrates] which results in increased expression of ACADVL more ... CTD PMID:35964746 Acadvl Rat Nutlin-3 multiple interactions ISO RGD:735407 6480464 [Dactinomycin co-treated with nutlin 3] results in increased expression of and results in increased secretion more ... CTD PMID:38460933 Acadvl Rat oleic acid multiple interactions ISO RGD:735407 6480464 [GW 4064 co-treated with Oleic Acid] results in decreased expression of ACADVL mRNA; [GW 7647 more ... CTD PMID:30611723 Acadvl Rat p-toluidine decreases expression EXP 6480464 4-toluidine results in decreased expression of ACADVL mRNA CTD PMID:27638505 Acadvl Rat paracetamol increases expression ISO RGD:735407 6480464 Acetaminophen results in increased expression of ACADVL mRNA CTD PMID:25704631 Acadvl Rat paracetamol decreases expression ISO RGD:735407 6480464 Acetaminophen results in decreased expression of ACADVL mRNA CTD PMID:26690555 Acadvl Rat perfluorooctane-1-sulfonic acid increases expression EXP 6480464 perfluorooctane sulfonic acid results in increased expression of ACADVL mRNA CTD PMID:18692542 Acadvl Rat perfluorooctane-1-sulfonic acid increases expression ISO RGD:10058 6480464 perfluorooctane sulfonic acid results in increased expression of ACADVL mRNA CTD PMID:19429403|PMID:20936131 Acadvl Rat perfluorooctanoic acid multiple interactions ISO RGD:10058 6480464 PPARA affects the reaction [perfluorooctanoic acid results in increased expression of ACADVL mRNA]; PPARA affects more ... CTD PMID:18467677|PMID:19751795 Acadvl Rat perfluorooctanoic acid increases expression ISO RGD:735407 6480464 perfluorooctanoic acid results in increased expression of ACADVL mRNA; perfluorooctanoic acid results in increased expression more ... CTD PMID:26879310|PMID:38199259 Acadvl Rat perfluorooctanoic acid increases expression ISO RGD:10058 6480464 perfluorooctanoic acid results in increased expression of ACADVL mRNA; perfluorooctanoic acid results in increased expression more ... CTD PMID:17681415|PMID:18467677|PMID:19429403|PMID:19751795|PMID:21499893 Acadvl Rat perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of ACADVL mRNA CTD PMID:19162173 Acadvl Rat picoxystrobin decreases expression ISO RGD:735407 6480464 picoxystrobin results in decreased expression of ACADVL mRNA CTD PMID:33512557 Acadvl Rat pirinixic acid increases expression ISO RGD:735407 6480464 pirinixic acid results in increased expression of ACADVL mRNA CTD PMID:18518955 Acadvl Rat pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of ACADVL mRNA CTD PMID:19162173|PMID:22484513|PMID:27665778 Acadvl Rat pirinixic acid increases expression ISO RGD:10058 6480464 pirinixic acid results in increased expression of ACADVL mRNA CTD PMID:16357043|PMID:17426115|PMID:18301758|PMID:18467677 Acadvl Rat pirinixic acid multiple interactions ISO RGD:10058 6480464 PPARA protein promotes the reaction [pirinixic acid results in increased expression of ACADVL mRNA] CTD PMID:18467677 Acadvl Rat piroxicam multiple interactions ISO RGD:735407 6480464 [Piroxicam co-treated with Cisplatin] results in decreased expression of ACADVL mRNA CTD PMID:21858171 Acadvl Rat propiconazole decreases expression ISO RGD:10058 6480464 propiconazole results in decreased expression of ACADVL mRNA CTD PMID:21278054 Acadvl Rat pyrimidifen decreases expression ISO RGD:735407 6480464 pyrimidifen results in decreased expression of ACADVL mRNA CTD PMID:33512557 Acadvl Rat quercetin increases expression ISO RGD:735407 6480464 Quercetin results in increased expression of ACADVL protein CTD PMID:15221776 Acadvl Rat rotenone decreases expression ISO RGD:735407 6480464 Rotenone results in decreased expression of ACADVL mRNA CTD PMID:33512557 Acadvl Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of ACADVL protein CTD PMID:35544339 Acadvl Rat SB 431542 increases expression ISO RGD:735407 6480464 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of ACADVL protein CTD PMID:25670856 Acadvl Rat SB 431542 multiple interactions ISO RGD:735407 6480464 [LDN 193189 co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of ACADVL more ... CTD PMID:37664457 Acadvl Rat sodium arsenate multiple interactions ISO RGD:735407 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in decreased expression of ACADVL more ... CTD PMID:32525701 Acadvl Rat sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of ACADVL protein CTD PMID:29459688 Acadvl Rat sodium chloride multiple interactions ISO RGD:735407 6480464 [Sodium Chloride co-treated with Furaldehyde] results in increased expression of and affects the localization of more ... CTD PMID:38598786 Acadvl Rat Soman increases expression EXP 6480464 Soman results in increased expression of ACADVL mRNA CTD PMID:19281266 Acadvl Rat sulforaphane increases expression ISO RGD:10058 6480464 sulforaphane results in increased expression of ACADVL mRNA CTD PMID:30529165 Acadvl Rat Tanshinone I increases expression ISO RGD:735407 6480464 tanshinone results in increased expression of ACADVL mRNA CTD PMID:15849732 Acadvl Rat Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of ACADVL mRNA CTD PMID:21515302 Acadvl Rat tetrachloromethane decreases expression ISO RGD:10058 6480464 Carbon Tetrachloride results in decreased expression of ACADVL mRNA CTD PMID:25270620 Acadvl Rat tetracycline decreases expression ISO RGD:10058 6480464 Tetracycline results in decreased expression of ACADVL mRNA CTD PMID:24489787 Acadvl Rat thapsigargin increases expression ISO RGD:735407 6480464 Thapsigargin results in increased expression of ACADVL mRNA CTD PMID:22378314 Acadvl Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ACADVL mRNA CTD PMID:34492290 Acadvl Rat tributylstannane increases expression ISO RGD:10058 6480464 tributyltin results in increased expression of ACADVL mRNA CTD PMID:23428407 Acadvl Rat trichloroethene increases expression ISO RGD:10058 6480464 Trichloroethylene results in increased expression of ACADVL mRNA; Trichloroethylene results in increased expression of ACADVL more ... CTD PMID:20709644 Acadvl Rat triphenyl phosphate affects expression ISO RGD:735407 6480464 triphenyl phosphate affects the expression of ACADVL mRNA CTD PMID:37042841 Acadvl Rat troglitazone increases expression EXP 6480464 troglitazone results in increased expression of ACADVL mRNA CTD PMID:21515302 Acadvl Rat tunicamycin increases expression ISO RGD:735407 6480464 Tunicamycin results in increased expression of ACADVL mRNA CTD PMID:22378314 Acadvl Rat valproic acid decreases expression ISO RGD:735407 6480464 Valproic Acid results in decreased expression of ACADVL mRNA CTD PMID:29154799 Acadvl Rat valproic acid increases expression ISO RGD:735407 6480464 Valproic Acid results in increased expression of ACADVL mRNA CTD PMID:23179753|PMID:27188386 Acadvl Rat valproic acid affects expression ISO RGD:735407 6480464 Valproic Acid affects the expression of ACADVL mRNA CTD PMID:25979313 Acadvl Rat zinc atom increases expression EXP 6480464 Zinc results in increased expression of ACADVL mRNA CTD PMID:17074742 Acadvl Rat zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of ACADVL mRNA CTD PMID:17074742 Acadvl Rat zinc(0) increases expression EXP 6480464 Zinc results in increased expression of ACADVL mRNA CTD PMID:17074742
Imported Annotations - SMPDB
Imported Annotations - KEGG (archival)
Imported Annotations - PID (archival)
1,2,4-trimethylbenzene (EXP) 1,2-dimethylhydrazine (ISO) 1,4-benzoquinone (ISO) 17beta-estradiol (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 2,6-dimethoxyphenol (ISO) 2-palmitoylglycerol (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 5-aza-2'-deoxycytidine (ISO) 6-propyl-2-thiouracil (EXP) acetamide (EXP) actinomycin D (ISO) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) ammonium chloride (EXP) antimycin A (ISO) aristolochic acid A (ISO) Aroclor 1254 (ISO) arsane (ISO) arsenic atom (ISO) aspartame (ISO) atrazine (ISO) azoxystrobin (ISO) benzo[a]pyrene (ISO) beta-lapachone (ISO) bezafibrate (ISO) bis(2-ethylhexyl) phthalate (EXP,ISO) bisphenol A (EXP,ISO) bisphenol AF (ISO) Bisphenol B (ISO) bisphenol F (ISO) Brodifacoum (EXP) butan-1-ol (ISO) cadmium atom (ISO) cadmium dichloride (ISO) cannabidiol (ISO) CHIR 99021 (ISO) chlorpyrifos (ISO) ciglitazone (ISO) cisplatin (ISO) clofibrate (EXP) Clofop (ISO) copper atom (EXP) copper(0) (EXP) cyclosporin A (ISO) dexamethasone (ISO) dibutyl phthalate (EXP) doxorubicin (ISO) endosulfan (EXP) epoxiconazole (ISO) ethanol (ISO) fenamidone (ISO) fenofibrate (EXP,ISO) flavonoids (EXP) flutamide (EXP) fructose (EXP) fulvestrant (ISO) furan (EXP) furfural (ISO) gemfibrozil (EXP) gold atom (ISO) gold(0) (ISO) GW 4064 (ISO) GW 501516 (ISO) GW 7647 (ISO) haloperidol (ISO) indometacin (EXP) isoprenaline (EXP) isotretinoin (ISO) ivermectin (ISO) leflunomide (EXP) lithocholic acid (ISO) meldonium (ISO) methapyrilene (EXP) methotrexate (ISO) microcystin-LR (ISO) mitoxantrone (ISO) monosodium L-glutamate (ISO) Muraglitazar (EXP) nitrates (ISO) Nutlin-3 (ISO) oleic acid (ISO) p-toluidine (EXP) paracetamol (ISO) perfluorooctane-1-sulfonic acid (EXP,ISO) perfluorooctanoic acid (EXP,ISO) picoxystrobin (ISO) pirinixic acid (EXP,ISO) piroxicam (ISO) propiconazole (ISO) pyrimidifen (ISO) quercetin (ISO) rotenone (EXP,ISO) SB 431542 (ISO) sodium arsenate (ISO) sodium arsenite (EXP) sodium chloride (ISO) Soman (EXP) sulforaphane (ISO) Tanshinone I (ISO) Tesaglitazar (EXP) tetrachloromethane (ISO) tetracycline (ISO) thapsigargin (ISO) thioacetamide (EXP) tributylstannane (ISO) trichloroethene (ISO) triphenyl phosphate (ISO) troglitazone (EXP) tunicamycin (ISO) valproic acid (ISO) zinc atom (EXP) zinc sulfate (EXP) zinc(0) (EXP)
Molecular Function
acyl-CoA dehydrogenase activity (IDA,IEA,ISO) fatty-acyl-CoA binding (IBA,IDA) flavin adenine dinucleotide binding (IDA,IEA,ISO) identical protein binding (IEA,ISO,ISS) long-chain fatty acyl-CoA dehydrogenase activity (IDA,IEA,ISO) oxidoreductase activity (IEA) oxidoreductase activity, acting on the CH-CH group of donors (IEA) protein binding (ISO) very-long-chain fatty acyl-CoA dehydrogenase activity (IBA,IDA,IEA,ISO)
1.
Rat very-long-chain acyl-CoA dehydrogenase, a novel mitochondrial acyl-CoA dehydrogenase gene product, is a rate-limiting enzyme in long-chain fatty acid beta-oxidation system. cDNA and deduced amino acid sequence and distinct specificities of the cDNA-expressed protein.
Aoyama T, etal., J Biol Chem 1994 Jul 22;269(29):19088-94.
2.
Rozhledy v chirurgii : mesícník Ceskoslovenské chirurgické spolecnosti
Bana J and Kralik J, Rozhl Chir 1978 Dec;57(12):813-20.
3.
[A rare type of bone involvement in scleroderma (author's transl)]
Bem Z and Birecka A, Pol Przegl Radiol Med Nukl 1978 Mar-Apr;42(2):115-7.
4.
Potential roles of PINK1 for increased PGC-1alpha-mediated mitochondrial fatty acid oxidation and their associations with Alzheimer disease and diabetes.
Choi J, etal., Mitochondrion. 2014 Sep;18:41-8. doi: 10.1016/j.mito.2014.09.005. Epub 2014 Sep 23.
5.
Identification of S-nitrosated mitochondrial proteins by S-nitrosothiol difference in gel electrophoresis (SNO-DIGE): implications for the regulation of mitochondrial function by reversible S-nitrosation.
Chouchani ET, etal., Biochem J. 2010 Aug 15;430(1):49-59. doi: 10.1042/BJ20100633.
6.
Asperuloside stimulates metabolic function in rats across several organs under high-fat diet conditions, acting like the major ingredient of Eucommia leaves with anti-obesity activity.
Fujikawa T, etal., J Nutr Sci. 2012 Sep 5;1:e10. doi: 10.1017/jns.2012.12. eCollection 2012.
7.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
8.
Acyl-CoA dehydrogenases. A mechanistic overview.
Ghisla S and Thorpe C, Eur J Biochem. 2004 Feb;271(3):494-508.
9.
Rat ISS GO annotations from GOA human gene data--August 2006
GOA data from the GO Consortium
10.
Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain acyl-coenzyme A dehydrogenase.
Izai K, etal., J Biol Chem. 1992 Jan 15;267(2):1027-33.
11.
The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model.
Jia X, etal., Life Sci. 2012 Jun 14;90(23-24):934-43. doi: 10.1016/j.lfs.2012.04.029. Epub 2012 Apr 30.
12.
KEGG: Kyoto Encyclopedia of Genes and Genomes
KEGG
13.
Selenium significantly inhibits adipocyte hypertrophy and abdominal fat accumulation in OLETF rats via induction of fatty acid beta-oxidation.
Kim JE, etal., Biol Trace Elem Res. 2012 Dec;150(1-3):360-70. doi: 10.1007/s12011-012-9519-1. Epub 2012 Oct 18.
14.
Inhibition of very long chain acyl-CoA dehydrogenase during cardiac ischemia.
Mason KE, etal., Arch Biochem Biophys. 2005 May 15;437(2):138-43. Epub 2005 Mar 19.
15.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
16.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
17.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
18.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
19.
PID Annotation Import Pipeline
Pipeline to import Pathway Interaction Database annotations from NCI into RGD
20.
SMPDB Annotation Import Pipeline
Pipeline to import SMPDB annotations from SMPDB into RGD
21.
RefSeq and LocusLink: NCBI gene-centered resources
Pruitt KD and Maglott DR, Nucleic Acids Res. 2001 Jan 1;29(1):137-40.
22.
Heat stress modulates hepatocyte membrane proteins during endotoxemia.
Przkora R, etal., Burns. 2007 Aug;33(5):628-33. Epub 2007 Mar 19.
23.
GOA pipeline
RGD automated data pipeline
24.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
25.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
26.
Bioenergetics in glutaryl-coenzyme A dehydrogenase deficiency: a role for glutaryl-coenzyme A.
Sauer SW, etal., J Biol Chem. 2005 Jun 10;280(23):21830-6. Epub 2005 Apr 19.
27.
Tentative Sequence Identification Numbers
Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
Acadvl (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 55,231,558 - 55,236,786 (-) NCBI GRCr8 mRatBN7.2 10 54,732,875 - 54,738,102 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 54,732,469 - 54,738,075 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 59,395,021 - 59,400,168 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 58,883,601 - 58,888,748 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 54,390,891 - 54,396,038 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 56,619,321 - 56,624,468 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 56,619,303 - 56,624,526 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 56,364,440 - 56,369,587 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 56,856,233 - 56,861,380 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 10 56,869,857 - 56,875,003 (-) NCBI Celera 10 53,886,459 - 53,891,606 (-) NCBI Celera Cytogenetic Map 10 q24 NCBI
ACADVL (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 7,217,125 - 7,225,266 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 7,217,125 - 7,225,266 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 7,120,444 - 7,128,585 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 7,063,877 - 7,069,309 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 17 7,063,956 - 7,069,306 NCBI Celera 17 7,147,787 - 7,153,219 (+) NCBI Celera Cytogenetic Map 17 p13.1 NCBI HuRef 17 7,012,512 - 7,020,576 (+) NCBI HuRef CHM1_1 17 7,129,209 - 7,137,334 (+) NCBI CHM1_1 T2T-CHM13v2.0 17 7,118,036 - 7,126,177 (+) NCBI T2T-CHM13v2.0
Acadvl (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 69,901,009 - 69,906,254 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 69,901,009 - 69,906,237 (-) Ensembl GRCm39 Ensembl GRCm38 11 70,010,183 - 70,015,428 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 70,010,183 - 70,015,411 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 69,823,694 - 69,828,909 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 69,826,387 - 69,831,602 (-) NCBI MGSCv36 mm8 Celera 11 77,558,144 - 77,563,359 (-) NCBI Celera Cytogenetic Map 11 B3 NCBI cM Map 11 42.96 NCBI
Acadvl (Chinchilla lanigera - long-tailed chinchilla)
Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955467 9,684,250 - 9,689,356 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955467 9,684,070 - 9,689,454 (-) NCBI ChiLan1.0 ChiLan1.0
ACADVL (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 14,812,517 - 14,817,937 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 16,778,578 - 16,783,944 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 7,249,717 - 7,255,165 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 7,236,286 - 7,242,417 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 17 7,234,283 - 7,242,417 (+) Ensembl panpan1.1 panPan2
ACADVL (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 5 32,189,191 - 32,194,255 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 5 32,186,502 - 32,327,990 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 5 32,327,393 - 32,332,562 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 5 32,294,698 - 32,299,874 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 5 32,292,139 - 32,335,711 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 5 32,260,008 - 32,265,180 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 5 32,219,055 - 32,224,215 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 5 32,395,976 - 32,401,145 (+) NCBI UU_Cfam_GSD_1.0
Acadvl (Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
ACADVL (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 12 52,576,402 - 52,581,748 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 12 52,573,521 - 52,581,755 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 3 139,851,936 - 139,857,148 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
ACADVL (Chlorocebus sabaeus - green monkey)
Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 16 6,593,288 - 6,598,980 (+) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 16 6,593,287 - 6,598,979 (+) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666059 14,811,795 - 14,817,522 (-) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Acadvl (Heterocephalus glaber - naked mole-rat)
.
Predicted Target Of
Count of predictions: 53 Count of miRNA genes: 51 Interacting mature miRNAs: 53 Transcripts: ENSRNOT00000024973 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
61441 Btemp1 Thermal response to stress QTL 1 4 body temperature trait (VT:0005535) core body temperature (CMO:0001036) 10 35392457 63642539 Rat 1549846 Scl47 Serum cholesterol level QTL 47 3.6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 10 50574707 95574707 Rat 9589136 Insul27 Insulin level QTL 27 10.46 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 10 11474010 56474010 Rat 152025229 Scl83 Serum cholesterol level QTL 83 4.33 blood cholesterol amount (VT:0000180) 10 35710580 68663659 Rat 1578779 Tcas10 Tongue tumor susceptibility QTL 10 3.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 10 31297439 76297439 Rat 152025227 Bw195 Body weight QTL 195 5.73 body mass (VT:0001259) 10 46989699 68663659 Rat 631564 Apr3 Acute phase response QTL 3 3.9 blood interleukin-6 amount (VT:0008595) plasma interleukin-6 level (CMO:0001927) 10 15275955 60275955 Rat 1298069 Bp168 Blood pressure QTL 168 5.5 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 10 26521957 98003205 Rat 2293669 Bmd33 Bone mineral density QTL 33 4.5 0.0001 femur strength trait (VT:0010010) femoral neck polar moment of inertia (CMO:0001670) 10 49444551 81709989 Rat 152025224 Bw193 Body weight QTL 193 6.47 body mass (VT:0001259) 10 51663405 75085664 Rat 631552 Vetf2 Vascular elastic tissue fragility QTL 2 4.5 0.0002 aorta elastic tissue integrity trait (VT:0010556) artery internal elastic lamina non-tumorous lesion count (CMO:0001913) 10 41142633 86142633 Rat 631554 Bp133 Blood pressure QTL 133 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 743364 63851208 Rat 631557 Bp136 Blood pressure QTL 136 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 30632053 75632053 Rat 61325 Aia5 Adjuvant induced arthritis QTL 5 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1298078 Stresp5 Stress response QTL 5 2.99 0.00025 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 42045676 104670812 Rat 2293679 Bmd30 Bone mineral density QTL 30 3.5 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 1578762 Toxo1 Toxoplasma gondii resistance QTL 1 brain integrity trait (VT:0010579) percentage of study population displaying Toxoplasma gondii brain cysts at a point in time (CMO:0002028) 10 52200030 59378278 Rat 2298544 Neuinf9 Neuroinflammation QTL 9 4.6 nervous system integrity trait (VT:0010566) spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126) 10 5801990 62146030 Rat 70164 Bw21 Body weight QTL 21 4.36 0.00005 body mass (VT:0001259) body weight (CMO:0000012) 10 53797494 98952626 Rat 61463 Bp12 Blood pressure QTL 12 6.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 41333258 86333258 Rat 8694173 Bw149 Body weight QTL 149 4.38 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 10 44441699 89441699 Rat 2300218 Hpcl2 Hepatic cholesterol level QTL 2 liver cholesterol amount (VT:0010498) liver cholesterol level (CMO:0001597) 10 45029650 95600334 Rat 1554317 Bmd4 Bone mineral density QTL 4 9.4 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 19816042 99406971 Rat 70171 Cari1 Carrageenan-induced inflammation QTL 1 4.9 0.0005 hypodermis integrity trait (VT:0010550) inflammatory exudate volume (CMO:0001429) 10 53797385 107211142 Rat 1598852 Anxrr19 Anxiety related response QTL 19 5.07 body movement coordination trait (VT:0005424) number of rearing movements in an experimental apparatus (CMO:0001752) 10 18167841 63167841 Rat 1581497 Esta1 Estrogen-induced thymic atrophy QTL 1 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 10 21329805 61345413 Rat 724527 Bp148 Blood pressure QTL 148 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 28453136 73453136 Rat 1358897 Stresp6 Stress response QTL 6 4.17 0.022 blood norepinephrine amount (VT:0005663) plasma norepinephrine level (CMO:0001010) 10 35392267 64155584 Rat 1331762 Rf40 Renal function QTL 40 3.873 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 10 29299504 64155584 Rat 2300171 Bmd58 Bone mineral density QTL 58 4.9 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 26944628 71944628 Rat 61354 Pia10 Pristane induced arthritis QTL 10 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2301967 Cm73 Cardiac mass QTL 73 4.55 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 10 14487011 89062041 Rat 2303118 Mamtr7 Mammary tumor resistance QTL 7 0.003 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 9658275 104670812 Rat 70188 BpQTLcluster1 Blood pressure QTL cluster 1 4.864 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 42323132 87323132 Rat 9590310 Scort19 Serum corticosterone level QTL 19 6.3 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 11474010 56474010 Rat 9589030 Epfw9 Epididymal fat weight QTL 9 19.24 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 10 44441699 89441699 Rat 10402859 Bp381 Blood pressure QTL 381 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2316949 Gluco60 Glucose level QTL 60 3.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 14487011 107057807 Rat 2293652 Bmd22 Bone mineral density QTL 22 4.9 0.0001 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 10 49444551 81709989 Rat 70198 BpQTLcluster9 Blood pressure QTL cluster 9 2.94 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 42323132 87323132 Rat 1359017 Hrtrt21 Heart rate QTL 21 2.4 heart pumping trait (VT:2000009) heart rate (CMO:0000002) 10 51772940 96772940 Rat 2306787 Ean3 Experimental allergic neuritis QTL 3 3.1 nervous system integrity trait (VT:0010566) body weight loss (CMO:0001399) 10 53797385 66979128 Rat 6893352 Bw100 Body weight QTL 100 0.33 0.6 body mass (VT:0001259) body weight (CMO:0000012) 1 15906665 60906665 Rat 724556 Pur2 Proteinuria QTL 2 5.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 22427500 90627625 Rat 8662860 Vetf10 Vascular elastic tissue fragility QTL 10 artery integrity trait (VT:0010639) number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562) 10 6154182 73453136 Rat 61387 Bp1 Blood pressure QTL 1 5.1 arterial blood pressure trait (VT:2000000) diastolic blood pressure (CMO:0000005) 10 51770177 107211142 Rat 1354585 Eae18a Experimental allergic encephalomyelitis QTL 18a 7.5 0.0004 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis severity score (CMO:0001419) 10 53797385 58445852 Rat 70223 Bp57 Blood pressure QTL 57 5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 1 80676123 Rat 1354587 Kidm21 Kidney mass QTL 21 3.3 kidney mass (VT:0002707) right kidney wet weight (CMO:0000082) 10 15028513 60430477 Rat 6893350 Bw99 Body weight QTL 99 0.87 0.16 body mass (VT:0001259) body weight (CMO:0000012) 1 15906665 60906665 Rat 2317043 Aia7 Adjuvant induced arthritis QTL 7 3.82 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 37565079 82565079 Rat 70224 Eae3 Experimental allergic encephalomyelitis QTL 3 4.1 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 10 26521957 61345413 Rat 2317042 Aia20 Adjuvant induced arthritis QTL 20 3.38 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 37565079 82565079 Rat 1331791 Cm31 Cardiac mass QTL 31 3.84606 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 29299504 107211142 Rat 2313087 Bmd80 Bone mineral density QTL 80 3.2 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 10 19606483 64606483 Rat 70364 Bp72 Blood pressure QTL 72 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 51121100 96121100 Rat 631530 Tls3 T-lymphoma susceptibility QTL 3 0 0.0001 thymus integrity trait (VT:0010555) percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911) 10 51774612 95600334 Rat 631535 Cm51 Cardiac mass QTL 51 3 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 10 51786282 91669536 Rat 1576319 Cia29 Collagen induced arthritis QTL 29 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 33973921 78973921 Rat 8552805 Bw145 Body weight QTL 145 2.2 body mass (VT:0001259) change in body weight to body weight ratio (CMO:0002216) 10 41944526 78307017 Rat 631267 Cia20 Collagen induced arthritis QTL 20 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2293705 Bmd25 Bone mineral density QTL 25 7.1 0.0001 femur mineral mass (VT:0010011) compact volumetric bone mineral density (CMO:0001730) 10 49444551 81709989 Rat 1576308 Schws1 Schwannoma susceptibility QTL 1 0.0041 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 10 40035094 102359817 Rat 631269 Cia22 Collagen induced arthritis QTL 22 8.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 631268 Cia21 Collagen induced arthritis QTL 21 3.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 14487011 104060283 Rat 9590268 Scort13 Serum corticosterone level QTL 13 3.26 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 11474010 56474010 Rat 7207811 Bmd90 Bone mineral density QTL 90 5.2 femur size trait (VT:1000369) femoral neck cross-sectional area (CMO:0001697) 10 49444551 81709989 Rat 1576311 Pia26 Pristane induced arthritis QTL 26 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 31224026 75632053 Rat 631270 Cia23 Collagen induced arthritis QTL 23 3.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 7411614 Foco18 Food consumption QTL 18 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 10 44441699 89441699 Rat 631547 Bp87 Blood pressure QTL 87 4.5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 47369470 92369470 Rat 61427 Cia16 Collagen induced arthritis QTL 16 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 6357896 96121100 Rat 6893342 Cm78 Cardiac mass QTL 78 0.1 0.88 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 42876766 79813922 Rat 2292441 Bp308 Blood pressure QTL 308 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2313055 Bw96 Body weight QTL 96 3.6 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 10 19606483 64606483 Rat 631542 Bp82 Blood pressure QTL 82 6.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 26521957 98952741 Rat
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000024973 ⟹ ENSRNOP00000024973
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 54,732,469 - 54,738,075 (-) Ensembl Rnor_6.0 Ensembl 10 56,619,303 - 56,624,526 (-) Ensembl
RefSeq Acc Id:
NM_012891 ⟹ NP_037023
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 55,231,558 - 55,236,705 (-) NCBI mRatBN7.2 10 54,732,875 - 54,738,022 (-) NCBI Rnor_6.0 10 56,619,321 - 56,624,468 (-) NCBI Rnor_5.0 10 56,364,440 - 56,369,587 (-) NCBI RGSC_v3.4 10 56,856,233 - 56,861,380 (-) RGD Celera 10 53,886,459 - 53,891,606 (-) RGD
Sequence:
TTCCGCGGCGGCTTTGGAGATGCAGTCGGCCCGGATGACCCCGAGTGTGGGGCGACAACTGCTGCGGCTGGGGGCCCGAAGCTCGCGGTCTGCTGCGCTTCAGGGACAACCCCGGCCTACCTCTGCCC AGCGACTTTATGCCAGTGAGGCCACTCAGGCAGTTCTGGAAAAGCCAGAGACCCTCTCCTCTGATGCTTCCACCAGAGAAAAACCTGCCAGGGCGGAATCTAAGTCTTTTGCTGTGGGAATGTTCAAA GGCCAGCTTACCACCGACCAGGTGTTCCCATACCCATCTGTGCTCAATGAAGGACAGACACAATTTCTCAAAGAGCTGGTGGGACCAGTGGCCCGGTTCTTTGAAGAAGTGAATGACCCTGCCAAGAA TGACTCCTTGGAGAAGGTGGAGGAGGACACTTTGCAGGGACTCAAAGAACTGGGGGCATTTGGTCTGCAAGTACCCAGCGAGCTGGGTGGTTTGGGCCTCTCTAATACCCAGTACGCTCGCTTGGCAG AGATTGTGGGCATGCATGACCTTGGTGTTAGCGTTACCCTGGGAGCCCATCAGAGCATCGGTTTCAAAGGCATCTTGCTCTATGGCACAAAGGCCCAGAAGGAAAAATACCTCCCCAGAGTGGCATCC GGGCAGGCTTTGGCGGCTTTCTGCCTGACTGAGCCCTCGAGCGGGTCCGATGTGGCCTCTATCCGAAGCTCAGCTGTACCTAGCCCCTGTGGAAAGTATTATACTCTCAACGGAAGCAAGATCTGGAT CAGTAATGGGGGTCTGGCAGACATTTTCACTGTCTTTGCCAAAACGCCAATTAAAGATGCAGCCACGGGGGCCGTGAAAGAGAAGATCACAGCTTTCGTAGTGGAACGGAGCTTTGGAGGGGTTACCC ATGGGCTCCCCGAAAAGAAGATGGGCATCAAGGCATCTAACACATCAGAGGTGTACTTTGATGGAGTCAAGGTGCCAGCAGAGAATGTGCTAGGAGAAGTGGGAGATGGCTTCAAGGTTGCTGTCAAC ATCCTCAACAACGGAAGATTTGGGATGGCTGCAACCCTAGCAGGCACCATGAAAGCCATCATTGCCAAGGCGGTTGATCATGCTACTAACCGTACCCAGTTTGGGGACAAAATTCACAACTTTGGGGT GATCCAGGAAAAGCTGGCTCGGATGGCTATTCTGCAGTATGTGACTGAGTCCATGGCTTACATGCTGAGTGCCAACATGGACCAGGGATTCAAAGACTTCCAGATAGAAGCTGCCATCAGCAAAATCT TTGGCTCGGAGGCGGCCTGGAAAGTGACAGATGAGTGCATCCAGATAATGGGGGGCATGGGCTTCATGAAGGAACCAGGGGTAGAGCGTGTGCTCCGAGATATTCGAATCTTCCGGATCTTTGAAGGG ACAAATGACATTCTTCGACTGTTTGTGGCTCTACAAGGCTGCATGGACAAAGGAAAGGAACTCACGGGACTTGGTAATGCCCTAAAGAATCCTCTTGGAAATGTTGGCCTCCTCATAGGAGAAGCAAG CAAACAGCTGAGGCGGCGGACAGGGATTGGCAGTGGTCTGAGTCTCTCGGGAATTGTCCACCCAGAGTTGAGTCGCAGTGGTGAACTGGCAGTGCAGGCTCTGGAACAATTTGCCACTGTAGTGGAGG CGAAGCTGATGAAGCACAAGAAAGGGATTGTCAATGAACAGTTCCTGCTGCAGCGACTGGCAGATGGAGCCATTGACCTCTACGCCATGGTGGTGGTTCTCTCCAGAGCCTCAAGATCCCTGAGTGAG GGCTACCCGACAGCACAGCATGAGAAAATGCTCTGTGATAGTTGGTGCATTGAGGCTGCAACACGGATTCGAGAAAACATGGCCAGCCTTCAGTCCAACCCTCAGCAGCAGGAGCTCTTTCGTAACTT CAGAAGTATCTCCAAGGCCATGGTGGAGAATGGTGGCCTGGTCACCAGTAACCCCCTTAGAGTCTGAAGACTCCTAATCAGGCCCTAGCACAGTCGTGTGCCTTCTTCTATGCCAAACACAGGCCCCC TTCATGGGGGCACTGGAGTACTTACTGCCTTAAGGACAATAAATTTTCTACCAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_063268458 ⟹ XP_063124528
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 55,233,882 - 55,236,786 (-) NCBI
RefSeq Acc Id:
NP_037023 ⟸ NM_012891
- Peptide Label:
precursor
- UniProtKB:
P45953 (UniProtKB/Swiss-Prot), F7FEX1 (UniProtKB/TrEMBL), Q5M9H2 (UniProtKB/TrEMBL)
- Sequence:
MQSARMTPSVGRQLLRLGARSSRSAALQGQPRPTSAQRLYASEATQAVLEKPETLSSDASTREKPARAESKSFAVGMFKGQLTTDQVFPYPSVLNEGQTQFLKELVGPVARFFEEVNDPAKNDSLEKV EEDTLQGLKELGAFGLQVPSELGGLGLSNTQYARLAEIVGMHDLGVSVTLGAHQSIGFKGILLYGTKAQKEKYLPRVASGQALAAFCLTEPSSGSDVASIRSSAVPSPCGKYYTLNGSKIWISNGGLA DIFTVFAKTPIKDAATGAVKEKITAFVVERSFGGVTHGLPEKKMGIKASNTSEVYFDGVKVPAENVLGEVGDGFKVAVNILNNGRFGMAATLAGTMKAIIAKAVDHATNRTQFGDKIHNFGVIQEKLA RMAILQYVTESMAYMLSANMDQGFKDFQIEAAISKIFGSEAAWKVTDECIQIMGGMGFMKEPGVERVLRDIRIFRIFEGTNDILRLFVALQGCMDKGKELTGLGNALKNPLGNVGLLIGEASKQLRRR TGIGSGLSLSGIVHPELSRSGELAVQALEQFATVVEAKLMKHKKGIVNEQFLLQRLADGAIDLYAMVVVLSRASRSLSEGYPTAQHEKMLCDSWCIEAATRIRENMASLQSNPQQQELFRNFRSISKA MVENGGLVTSNPLRV
hide sequence
Ensembl Acc Id:
ENSRNOP00000024973 ⟸ ENSRNOT00000024973
RefSeq Acc Id:
XP_063124528 ⟸ XM_063268458
- Peptide Label:
isoform X1
RGD ID: 13697345
Promoter ID: EPDNEW_R7870
Type: initiation region
Name: Acadvl_1
Description: acyl-CoA dehydrogenase, very long chain
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 10 56,624,517 - 56,624,577 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2011-07-28
Acadvl
acyl-CoA dehydrogenase, very long chain
Acadvl
acyl-Coenzyme A dehydrogenase, very long chain
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2003-04-09
Acadvl
acyl-Coenzyme A dehydrogenase, very long chain
Acyl-Coa dehydrogenase, Very long chain
Name updated
629478
APPROVED
2002-06-10
Acadvl
Acyl-Coa dehydrogenase, Very long chain
Symbol and Name status set to approved
70586
APPROVED
Note Type
Note
Reference
gene_cellular_localization
localized to mitochondria
631729
gene_function
catalyzes the beta-oxidation of long-chain fatty acids
631729
gene_process
plays a role in long chain fatty acid metabolism
631729
gene_product
member of the acyl-CoA dehydrogenase family
631729
gene_protein
655 amino acid sequence with 40 amino acid leader sequence and 615 amino acid residues in the mature protein
631729